Navigation Links
Progen Investor Teleconference Dial In Details
Date:2/4/2008

BRISBANE, Australia, Feb. 4 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals' Management Team (ASX: PGL; Nasdaq: PGLA) will be conducting an investor teleconference on Tuesday 5 February at 9.00am Australian (Sydney time) and Monday 4 February at 5:00pm US EST.

The Management Team will present an overview of the Cellgate, Inc. acquisition and will be available to answer your queries.
Please refer to the relevant presentation at: http://www.progen-pharma.com

Please follow the dial-in instructions below:

National toll free - Australia - 1800 701 269

Country International Time of Teleconference call

toll free numbers: in the relevant locations

United Kingdom 1080 0264 0084 Monday, 4 February 2008 at 10:00 PM

Hong Kong 800 968 831 Tuesday, 5 February 2008 at 6:00 AM

Japan 0053 125 0068 Tuesday, 5 February 2008 at 7:00 AM

Singapore 800 616 3092 Tuesday, 5 February 2008 at 6:00 AM

Taiwan 008 0161 5152 Tuesday, 5 February 2008 at 6:00 AM

New Zealand 080 044 6041 Tuesday, 5 February 2008 at 11:00 AM

USA 1866 2421 388 Monday, 4 February at 2.00 PM PST

Monday, 4 February at 5.00 PM EST

International toll - + 61 2 8823 6760

Then dial conference identification number: 33563946

If your country is not listed, and you would like to participate on the call, please contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Elusive pancreatic progenitor cells found in mice
2. Imaging neural progenitor cells in the living human brain
3. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
5. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
6. Stryker to Present at Investor Conference
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
8. GSI to Present at Upcoming Investor Growth Conferences
9. WebMD to Present at Upcoming Investor Conferences
10. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
11. Mindray to Attend 2008 CLSA Asia Investors Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: